TY  - GEN
AU  - Brown,Jennifer R
AU  - Friedberg,Jonathan W
AU  - Feng,Yang
AU  - Scofield,Sarah
AU  - Phillips,Kimberly
AU  - Dal Cin,Paola
AU  - Joyce,Robin
AU  - Takvorian,Ronald W
AU  - Fisher,David C
AU  - Fisher,Richard I
AU  - Liesveld,Jane
AU  - Marquis,Diana
AU  - Neuberg,Donna
AU  - Freedman,Arnold S
TI  - A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas
SN  - 1365-2141
PY  - 2009///0910
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Disease-Free Survival
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Lymphoma
KW  - drug therapy
KW  - Lymphoma, B-Cell, Marginal Zone
KW  - Lymphoproliferative Disorders
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Rituximab
KW  - Survival Rate
KW  - Vidarabine
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1111/j.1365-2141.2009.07677.x
ER  -